# FDA 483 - Nanophase Technologies Corporation - January 09, 2026

Source: https://www.keypedia.com/records/483/nanophase-technologies-corporation/d0c38f26-1627-4403-aa2e-617603743fdd

> FDA 483 for Nanophase Technologies Corporation on January 09, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Nanophase Technologies Corporation
- Inspection Date: 2026-01-09
- Product Type: drugs
- Office Name: Chicago District Office
- Summary: An FDA inspection of Solesence, Inc. in Romeoville, IL, an API manufacturer, revealed that processes for the production of Active Pharmaceutical Ingredients were not followed in writing. Specifically, an operator began a batch without an issued batch record, and critical operating parameters were found to be outside specified ranges. These issues indicate a lack of adherence to established manufacturing procedures.

## Related Documents

- [483 - 2023-04-13](https://www.keypedia.com/records/483/nanophase-technologies-corporation/8272f957-6c93-4953-a84a-545653f7e600)
- [483 - 2026-01-09](https://www.keypedia.com/records/483/nanophase-technologies-corporation/a954b706-d43a-415e-acbb-b885f003b3de)

## Related Officers

- [Tyler M. Peterson](https://www.keypedia.com/people/tyler-m-peterson/207310ee-260c-4618-a515-9895a56e2ede)
- [Kelly M. Bromley](https://www.keypedia.com/people/kelly-m-bromley/964704be-b203-4c56-b1d7-6144e9e0236e)

Company: https://www.keypedia.com/companies/nanophase-technologies-corporation/2b2b4bbe-7d35-4ece-8a79-dbffc6f82a51

Office: https://www.keypedia.com/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669